BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

337 related articles for article (PubMed ID: 17123452)

  • 41. Expression of heat shock protein 27 in human renal cell carcinoma.
    Sarto C; Valsecchi C; Magni F; Tremolada L; Arizzi C; Cordani N; Casellato S; Doro G; Favini P; Perego RA; Raimondo F; Ferrero S; Mocarelli P; Galli-Kienle M
    Proteomics; 2004 Aug; 4(8):2252-60. PubMed ID: 15274119
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Serum protein profiling to identify biomarkers for small renal cell carcinoma.
    Xu G; Hou CR; Jiang HW; Xiang CQ; Shi N; Yuan HC; Ding Q; Zhang YF
    Indian J Biochem Biophys; 2010 Aug; 47(4):211-8. PubMed ID: 21174948
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Systematic comparative protein expression profiling of clear cell renal cell carcinoma: a pilot study based on the separation of tissue specimens by two-dimensional gel electrophoresis.
    Lichtenfels R; Dressler SP; Zobawa M; Recktenwald CV; Ackermann A; Atkins D; Kersten M; Hesse A; Puttkammer M; Lottspeich F; Seliger B
    Mol Cell Proteomics; 2009 Dec; 8(12):2827-42. PubMed ID: 19752005
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Comparison of clinicopathological parameters with FoxM1 expression in renal cell carcinoma.
    Kocarslan S; Guldur ME; Ekinci T; Ciftci H; Ozardali HI
    J Cancer Res Ther; 2014; 10(4):1076-81. PubMed ID: 25579557
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Differencial proteome of clear-cell renal cell carcinoma (ccRCC) tissues.
    Vieira de Ribeiro AJ; Sandim V; Ornellas AA; Reis RS; Domont G; Alves G
    Int Braz J Urol; 2013; 39(1):83-94. PubMed ID: 23510786
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Significance of heat shock protein-27 expression in patients with renal cell carcinoma.
    Erkizan O; Kirkali G; Yörükoğlu K; Kirkali Z
    Urology; 2004 Sep; 64(3):474-8. PubMed ID: 15351573
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Personalized discovery of altered pathways in clear cell renal cell carcinoma using accumulated normal sample data.
    Wang X; Ding M; Yang Y; Feng Y; Shi Z; Qiu F; Zhu M
    J BUON; 2016; 21(2):390-8. PubMed ID: 27273949
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Identification of markers for the selection of patients undergoing renal cell carcinoma-specific immunotherapy.
    Seliger B; Menig M; Lichtenfels R; Atkins D; Bukur J; Halder TM; Kersten M; Harder A; Ackermann A; Beck J; Muehlenweg B; Brenner W; Melchior S; Kellner R; Lottspeich F
    Proteomics; 2003 Jun; 3(6):979-90. PubMed ID: 12833523
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Grade-Dependent Metabolic Reprogramming in Kidney Cancer Revealed by Combined Proteomics and Metabolomics Analysis.
    Wettersten HI; Hakimi AA; Morin D; Bianchi C; Johnstone ME; Donohoe DR; Trott JF; Aboud OA; Stirdivant S; Neri B; Wolfert R; Stewart B; Perego R; Hsieh JJ; Weiss RH
    Cancer Res; 2015 Jun; 75(12):2541-52. PubMed ID: 25952651
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Heat shock protein expression and anti-heat shock protein reactivity in renal cell carcinoma.
    Lichtenfels R; Kellner R; Bukur J; Beck J; Brenner W; Ackermann A; Seliger B
    Proteomics; 2002 May; 2(5):561-70. PubMed ID: 11987130
    [TBL] [Abstract][Full Text] [Related]  

  • 51. 14-3-3 protein beta/alpha as a urinary biomarker for renal cell carcinoma: proteomic analysis of cyst fluid.
    Minamida S; Iwamura M; Kodera Y; Kawashima Y; Tabata K; Matsumoto K; Fujita T; Satoh T; Maeda T; Baba S
    Anal Bioanal Chem; 2011 Jul; 401(1):245-52. PubMed ID: 21553213
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Distinct von Hippel-Lindau gene and hypoxia-regulated alterations in gene and protein expression patterns of renal cell carcinoma and their effects on metabolism.
    Leisz S; Schulz K; Erb S; Oefner P; Dettmer K; Mougiakakos D; Wang E; Marincola FM; Stehle F; Seliger B
    Oncotarget; 2015 May; 6(13):11395-406. PubMed ID: 25890500
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Urine metabolomics analysis for kidney cancer detection and biomarker discovery.
    Kim K; Aronov P; Zakharkin SO; Anderson D; Perroud B; Thompson IM; Weiss RH
    Mol Cell Proteomics; 2009 Mar; 8(3):558-70. PubMed ID: 19008263
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Proteomic analysis of primary cell lines identifies protein changes present in renal cell carcinoma.
    Craven RA; Stanley AJ; Hanrahan S; Dods J; Unwin R; Totty N; Harnden P; Eardley I; Selby PJ; Banks RE
    Proteomics; 2006 May; 6(9):2853-64. PubMed ID: 16596713
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The Coordinated Actions of TIM-3 on Cancer and Myeloid Cells in the Regulation of Tumorigenicity and Clinical Prognosis in Clear Cell Renal Cell Carcinomas.
    Komohara Y; Morita T; Annan DA; Horlad H; Ohnishi K; Yamada S; Nakayama T; Kitada S; Suzu S; Kinoshita I; Dosaka-Akita H; Akashi K; Takeya M; Jinushi M
    Cancer Immunol Res; 2015 Sep; 3(9):999-1007. PubMed ID: 25783986
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Identification of proteins differentially expressed in the conventional renal cell carcinoma by proteomic analysis.
    Hwa JS; Park HJ; Jung JH; Kam SC; Park HC; Kim CW; Kang KR; Hyun JS; Chung KH
    J Korean Med Sci; 2005 Jun; 20(3):450-5. PubMed ID: 15953868
    [TBL] [Abstract][Full Text] [Related]  

  • 57. iTRAQ-Based Quantitative Proteomic Analysis Identified HSC71 as a Novel Serum Biomarker for Renal Cell Carcinoma.
    Zhang Y; Cai Y; Yu H; Li H
    Biomed Res Int; 2015; 2015():802153. PubMed ID: 26425554
    [TBL] [Abstract][Full Text] [Related]  

  • 58. High-level S100A6 promotes metastasis and predicts the outcome of T1-T2 stage in clear cell renal cell carcinoma.
    Lyu X; Li H; Ma X; Li X; Gao Y; Ni D; Shen D; Gu L; Wang B; Zhang Y; Zhang X
    Cell Biochem Biophys; 2015 Jan; 71(1):279-90. PubMed ID: 25120023
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Gene expression analysis of renal carcinoma: adipose differentiation-related protein as a potential diagnostic and prognostic biomarker for clear-cell renal carcinoma.
    Yao M; Tabuchi H; Nagashima Y; Baba M; Nakaigawa N; Ishiguro H; Hamada K; Inayama Y; Kishida T; Hattori K; Yamada-Okabe H; Kubota Y
    J Pathol; 2005 Feb; 205(3):377-87. PubMed ID: 15682440
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Blood- and Urine-Based Liquid Biopsy for Early-Stage Cancer Investigation: Taken Clear Renal Cell Carcinoma as a Model.
    Liu X; Zhang M; Shao C; Sun H; Zhang B; Guo Z; Sun J; Qi F; Zhang Y; Niu H; Sun W
    Mol Cell Proteomics; 2023 Aug; 22(8):100603. PubMed ID: 37348606
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.